UL
Ulys LLC Portfolio holdings
AUM
$25.4M
This Quarter Return
+25.92%
1 Year Return
+201.03%
3 Year Return
-31.51%
5 Year Return
-50.88%
10 Year Return
–
AUM
$78.1M
AUM Growth
+$78.1M
(+26%)
Cap. Flow
-$2K
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
CERE
CERES, INC. COMMON STOCK NEW
CERE
|
$2K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Lexicon Pharmaceuticals
LXRX
$400M
| $78.1M | 100% | 4,321,214 | – | – |
|
|
CERE
2
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| – | – | -3,891 | Closed | -$2K |
|